Radiotherapeutic treatment of Peyronie's disease

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 4, Issue 2, 2004, Pages 235-242

  Incrocci, Luca ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Erectile dysfunction; Penile curvature; Penile pain; Peyronie's disease; Radiation; Radiotherapy

Indexed keywords

4 AMINOBENZOATE POTASSIUM; ALPHA TOCOPHEROL; CALCIUM ANTAGONIST; CARNITINE; COLCHICINE; COLLAGENASE; CORTICOSTEROID; IBUPROFEN; INTERFERON; PLACEBO; TAMOXIFEN; VERAPAMIL;

ATROPHY; CLINICAL TRIAL; DIAGNOSTIC TEST; DRUG EFFICACY; ERECTILE DYSFUNCTION; EXCISION; EXTRACORPOREAL LITHOTRIPSY; HUMAN; MALE; PENILE FIBROSIS; PEYRONIE DISEASE; RADIATION DOSE; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 1842502858     PISSN: 14737167     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737167.4.2.235     Document Type: Review

References (67)

1. de la Peyronie FG. Sur quelques obstacles qui s'opposent à l'ejaculation naturelle de la semence. Mem. Acad. R. Chir. 1, 425-434 (1743).
2. Hauck EW, Weidner W. François de la Peyronie and the disease named after him. Lancet 357, 2049-2051 (2001).
3. Sommer F, Schwarzer U, Wassmer G et al. Epidemiology of Peyronie's disease. Int. J. Impot. Res. 14, 379-383 (2002).
4. La Pera G, Pescatori ES, Calabrese M et al. Peyronie's disease: Prevalence and association with cigarette smoking. Eur. Urol. 40, 525-530 (2001).
5. Lyles KW, Goldt DT, Newton RA et al. Peyronie's disease is associated with Paget's disease of bone. J. Bone Min. Res. 12, 929-934 (1997).
6. Carrieri MP, Serraino D, Palmiotto F, Nucci G, Sasso F. A case-control study on risk factors for Peyronie's disease. J. Clin. Epidemiol. 51, 511-515 (1998).
7. Ralph DJ, Schwartz G, Moore W, Pryor JP, Ebringer A, Bottazzo GF. The genetic and bacteriological aspects of Peyronie's disease. J. Urol. 157, 291-294 (1997).
8. Brock G, Hsu GL, Nunes L, von Heyden B, Lue TF. The anatomy of the tunica albuginea in the normal penis and Peyronie's disease. J. Urol. 157, 276-281 (1997).
9. Devine CJ, Somers KD, Jordan GH, Schlossberg SM. Proposal: trauma as the cause of the Peyronie's lesion. J. Urol. 157, 285-290 (1997).
10. Jarow JP, Lowe FC. Penile trauma: An etiologic factor in Peyronie's disease and erectile dysfunction. J. Urol. 158, 1388-1390 (1997).
11. Davis CJ Jr. The microscopic pathology of Peyronie's disease. J. Urol. 157, 282-284 (1997).
12. Somers KD, Dawson DM. Fibrin deposition in Peyronie's disease plaque. J. Urol. 157, 311-315 (1997).
13. Diegelmann RF. Cellular and biochemical aspects of normal and abnormal wound healing: An overview. J. Urol. 157, 298-302 (1997).
14. Ehrlich HP. Scar contracture: Cellular and connective tissue aspects in Peyronie's disease. J. Urol. 157, 316-319 (1997).
15. Magee TR, Qian A, Rajfer J et al. Gene expression profiles in the Peyronie's disease plaque. Urology 59, 451-457 (2002).
16. Moreland RB, Nehra A. Pathofysiology of Peyronie's disease. Int. J. Impot. Res. 14, 406-410 (2002).
17. Devine CJ, Horton CE. Peyronie's disease. Clin. Plast. Surg. 15, 405-409 (1988).
18. Gelbard MK, Dorey F, James K. The natural history of Peyronie's disease. J. Urol. 144, 1376-1379 (1990).
19. Pryor JP, Ralph DJ. Clinical presentation of Peyronie's disease. Int. J. Impot. Res. 14, 414-417 (2002).
20. Lue TF, Gelbard MK, Gueglio G et al. Peyronie's disease. In: Erectile Dysfunction. Jardin A. Wagner G, Khoury S, Giuliano F, Padma-Nathan H, Rosen R (Eds). Health Publication Limited, Plymouth, UK, 439-475 (2000).
21. Hakim LS. Peyronie's disease: An update. The role of diagnostics. Int. J. Impot. Res. 14, 321-323 (2002).
22. Hauck EW, Hackstein N, Vosshenrich R et al. Diagnostic value of magnetic resonance imaging in Peyronie's disease - a comparison both with palpation and ultrasound in the evaluation of plaque formation. Eur. Urol. 43, 293-300 (2003).
23. Lopez JA, Jarow JP. Penile vascular evaluation of men with Peyronie's disease. J. Urol. 149, 53-55 (1993).
24. Montorsi F, Guazzoni G, Bergamaschi F et al. Vascular abnormalities in Peyronie's disease: The role of color Doppler sonography, J. Urol. 151, 373-375 (1994).
25. Weidner W, Schroeder-Printzen I, Weiske WF, Vosshenrich R. Sexual dysfunction in Peyronie's disease: An analysis of 222 patients without previous plaque therapy. J. Urol. 157, 325-328 (1997).
26. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF). A multidimensional scale for assessment of erectile dysfunction. Urology 49, 822-830 (1997).
27. Scott WW, Scardino PL. A new concept in the treatment of Peyronie's disease. South Med. J. 41, 173-177 (1948).
28. Wagenknecht LV. Differential therapies in various stages of penile induration. Arch Esp. Urol. 49, 285-292 (1996).
29. Akkus E, Carrier S, Rehman J, Breza J, Kadioglu A, Lue TF. Is colchicine effectieve in Peyronie's disease? A pilot study. Urology 44, 291-295 (1997).
30. Kadioglu A, Tefekli A, Köksal T, Usta M, Erol H. Treatment of Peyronie's disease with oral colchicine: Long-term results and predictive parameters of successful outcome. Int. J. Impot. Res. 12, 169-175 (2000).
31. Prieto Castro RM, Leva Vallejo ME, Lopez Regueiro JC, Anglada Curado FJ, Alvarez Kindelan J, Requena Tapia MJ. Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease. BJU Int. 91, 522-524 (2003).
32. Ralph DJ, Brooks MD, Bottazzo GF, Pryor JP. The treatment of Peyronie's disease with tamoxifen. Br. J. Urol. 70, 648-651 (1992).
33. Teloken C, Rhoden EL, Grazziottin TM, Da Ros CT, Sogari PR, Souto CAV. Tamoxifen versus placebo in the treatment of Peyronie,s disease. J. Urol. 162, 2003-2005 (1999).
34. Gelbard MK, James K, Riach R Dovr F. Collagenase versus placebo in the treatment of Peyronie's disease: A double-blind study. J. Urol. 149, 56-58 (1993).
35. Levine LA, Merrick PF, Lee RC. Intralesional verapamil injection for the treatment of Peyronie's disease. J. Urol. 151, 1522-1524 (1994).
36. Levine LA. Treatment of Peyronie's disease with intralesional verapamil injection. J. Urol. 158, 1395-1399 (1997).
37. Levine AL, Goldman KE, Greenfield JM. Experience with intraplaque injection of verapamil for Peyronie's disease. J. Urol. 168, 621-626 (2002).
38. Cavallini G, Biagiotti G, Koverech A, Vitali G. Oral propionyl-L-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease. BJU Int. 89, 895-900 (2002).
39. Wegner H, Andresen R, Knispel H, Miller K. Treatment of Peyronie's disease with local interferon-α 2b. Eur. Urol. 28, 236-240 (1995).
40. Judge IS, Wisniewski ZS. Intralesional interferon in the treatment of Peyronie's disease: A pilot study. Br. J. Urol. 79, 40-42 (1997).
41. Brake N, Loertzer H, Horsch R, Keller H. Treatment of Peyronie's disease with local interferon-α 2b. BJU Int. 87, 654-657 (2001).
42. Lebret T, Loison G, Hervé JM et al. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: Experience with standard lithotriptor (Siemens-multiline). Urology 59, 657-661 (2002).
43. Manikandan R, Islam W, Srinivasan V, Evans CM. Evaluation of extracorporeal shock wave therapy in Peyronie's disease. Urology 60, 795-800 (2002).
44. Hamm R, McLarty E, Ashdown J, Natale S, Dickinson A. Peyronie's disease - the Plymouth experience of extracorporeal shockwave treatment. BJU Int. 87, 849-852 (2001).
45. Husain J, Lynn NNK, Jones DK, Collins GN, O'Reilly PH. Extracorporeal shock wave therapy in the management of Peyronie's disease: Initial experience. BJU Int. 86, 466-468 (2000).
46. Kelami A. Classification of congenital and acquired penile deviation. Urol. Int. 38, 229-233 (1983).
47. Pryor J, Fitzpatrick J. A new approach to the correction of the penile deformity in Peyronie's disease. J. Urol. 122, 622-623 (1979).
48. Ralph D, Al-Akraa M, Pryor J. The Nesbit operation for Peyronie's disease: 16- year experience. J. Urol. 154, 1362-1363 (1995).
49. Levine LA, Lenting EL. A surgical algorithm for the treatment of Peyronie's disease. J. Urol. 158, 2149-2152 (1997).
50. Trott KR, Kamprad F. Radiobiological mechanisms of anti-inflammatory radiotherapy. Radiother. Oncol. 51, 197-203 (1999).
51. Leer JWH, van Houtte P, Davelaar J. Indications and treatment schedules for irradiation of benign disease: A survey. Radiother. Oncol. 48, 249-257 (1998).
52. Fricke RE, Olds JW. The radium treatment of Peyronie's disease. AJR 42, 545-550 (1939).
53. Dahl O. Treatment of plastic induration of penis (Peyronie's disease). Acta Radiol. 41, 290-301 (1954).
54. Duggan HE. Effect of x-ray therapy on patients with Peyronie's disease. J. Urol. 91, 572-574 (1964).
55. Dunlap JC, Lathem JE. X-ray therapy in Peyronie's disease. South Med. J. 62, 1485-1486 (1969).
56. Griff LC. Peyronie's disease. The role of radiation therapy and a general review. AJR 100, 916-919 (1967).
57. Williams JL, Thomas GG. The natural history of Peyronie's disease. J. Urol. 103, 75-76 (1970).
58. Helvie WW, Fiske Ochsner S. Radiation therapy in Peyronie's disease. South Med. J. 65, 1192-1996 (1972).
59. Martin CL. Long time study of patients with Peyronie's disease treated with irradiation. AJR 114, 492-497 (1972).
60. Poutasse EF. Peyronie's disease. J. Urol. 107, 419-422 (1972).
61. Furlow WL, Swenson HE Jr, Lee RE. Peyronie's disease: A study of its natural history and treatment with orthovoltage radiotherapy. J. Urol. 114, 69-71 (1975).
62. Carson CC, Coughlin PWF. Radiation therapy for Peyronie's disease: Is there a place? J. Urol. 134, 684-686 (1985).
63. Mira JG, Chahbazian CM, del Regato JA. The value of radiotherapy for Peyronie's disease: Presentation of 56 new case studies and review of the literature. Int. J. Radiat. Oncol. Biol. Phys. 6, 161-166 (1980).
64. Viljoen IM, Goedhals L, Doman MJ. Peyronie's disease - a perspective on the disease and the long-term results of radiotherapy. S. Afr. Med. J. 83, 19-20 (1993).
65. Rodrigues CI, Njo KH, Karim ABMF. Results of radiotherapy and vitamin E in the treatment of Peyronie's disease. Int. J. Radiat. Oncol. Biol. Phys. 31, 571-576 (1995).
66. Incrocci L, Wijnmaalen A, Slob AK, Hop WCJ, Levendag PC. Low-dose radiotherapy in 179 patients with Peyronie's disease: Treatment outcome and current sexual functioning. Int. J. Radiat. Oncol. Biol. Phys. 47, 1353-1356 (2000).
67. Incrocci L, Hop WCJ, Slob AK. Current sexual functioning in 106 patients with peyronie's disease, treated with radiotherapy 9 years earlier. Urology 56, 1030-1034 (2000).